StockData
Corcept Therapeutics Inc logo

Corcept Therapeutics Inc (CORT) stock

CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30537% above fair value
$70.07+0.85 (+1.23%)

Close on Nov 17, 2026Market cap $7.57BP/E 166.8Yield –

Corcept Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Corcept Therapeutics's market cap was $8.61B on Nov 11, 2026, against $9.51B a year earlier. Over the last 5 years it ranged from $2.25B to $13.32B, with a median of $3.75B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.61B+106.7%
2025Dec 31, 2025$4.17B-25.8%
2024Dec 31, 2024$5.61B+52.8%
2023Dec 29, 2023$3.67B+54.2%
2022Dec 30, 2022$2.38B-5.3%
2021Dec 31, 2021$2.52B-21.9%
2020Dec 31, 2020$3.22B+116.2%
2019Dec 31, 2019$1.49B-12.4%
2018Dec 31, 2018$1.70B-17.5%
2017Dec 29, 2017$2.06B+155.9%
2016Dec 30, 2016$805.00M+48.6%
2015Dec 31, 2015$541.55M+78.5%
2014Dec 31, 2014$303.42M-5.3%
2013Dec 31, 2013$320.40M+151.5%
2012Dec 31, 2012$127.40M-50.9%
2011Jul 29, 2011$259.21M–

More Corcept Therapeutics figures

See a number that looks wrong?